The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Tubulin-Interactive Natural Products as Anticancer Agents
Open accessAbstract
This review provides an overview of the discovery, structures, and biological activities of anticancer natural products that act by inhibiting or promoting the assembly of tubulin to microtubules. The emphasis is on providing recent information on those compounds in clinical use or in advanced clinical trials. The vinca alkaloids, the combretastatins, NPI-2358, the halichondrin B analogue eribulin, dolastatin 10, noscapine, hemiasterlin, and rhizoxin are discussed as tubulin polymerization inhibitors, while the taxanes and the epothilones are the major classes of tubulin polymerization promoters presented, with brief treatments of discodermolide, eleutherobin, and laulimalide. The challenges and future directions of tubulin-interactive natural products-based drug discovery programs are also discussed briefly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Lessons from natural molecules
Clardy, J., & Walsh, C. (2004) · Nature · doi:10.1038/nature03194 · Cited by 1,171
Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson
Löwe, J., Li, H., Downing, K. H., & Nogales, E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5077 · Cited by 1,145
McGuire, W. P., Rowinsky, E. K., Rosenshein, N. B., Grumbine, F. C., Ettinger, D. S., Armstrong, D. K., & Donehower, R. C. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-4-273 · Cited by 1,100
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Feher, M., & Schmidt, J. M. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0200467 · Cited by 927
THE IMPACT OF NATIONAL CANCER ACT
(1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797 · Cited by 796
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S., & Garcia-Kendal, D. (1989) · Experientia · doi:10.1007/bf01954881 · Cited by 786
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
Holmes, F. A., Walters, R. S., Theriault, R. L., Buzdar, A. U., Frye, D. K., Hortobagyi, G. N., Forman, A. D., Newton, L. K., & Raber, M. N. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.24.1797-a · Cited by 746
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O. D., Koupal, L. R., Liesch, J. M., Goetz, M., Lazarides, E., & Woods, C. M. (1995) · PubMed · Cited by 685
Anticancer Agents from Natural Products
(2005) · CRC Press eBooks · doi:10.1201/9781420039658 · Cited by 638
Medicinal Chemistry of Combretastatin A4: Present and Future Directions
Tron, G. C., Pirali, T., Sorba, G., Pagliai, F., Busacca, S., & Genazzani, A. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512903 · Cited by 629
The Renaissance of Natural Products as Drug Candidates
Paterson, I., & Anderson, E. A. (2005) · Science · doi:10.1126/science.1116364 · Cited by 559
Halichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Jordan, M. A., Kamath, K., Manna, T., Okouneva, T., Miller, H. P., Davis, C., Littlefield, B. A., & Wilson, L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0345 · Cited by 489
Paciotti, G. F., Kingston, D. G. I., & Tamarkin, L. (2006) · Drug Development Research · doi:10.1002/ddr.20066 · Cited by 484
Self-citationTaxol and taxotere: discovery, chemistry, and structure-activity relationships
Guenard, D., Gueritte-Voegelein, F., & Potier, P. (1993) · Accounts of Chemical Research · doi:10.1021/ar00028a005 · Cited by 444
ROLE OF CHANCE OBSERVATIONS IN CHEMOTHERAPY: VINCA ROSEA*
Noble, R. L., Beer, C. T., & Cutts, J. H. (1958) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1958.tb54906.x · Cited by 407
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Discodermolide, A Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol,
ter Haar, E., Kowalski, R. J., Hamel, E., Lin, C. M., Longley, R. E., Gunasekera, S. P., Rosenkranz, H. S., & Day, B. W. (1996) · Biochemistry · doi:10.1021/bi9515127 · Cited by 382
Bai, R. L., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., & Hamel, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98491-7 · Cited by 379
Gunasekera, S. P., Gunasekera, M., Longley, R. E., & Schulte, G. K. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00303a029 · Cited by 375
Ye, K., Ke, Y., Keshava, N., Shanks, J., Kapp, J. A., Tekmal, R. R., Petros, J., & Joshi, H. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1601 · Cited by 341
Taxol®: science and applications.
Suffness, M., Wall, M. E., Hartzell, H. R., Croom, E. M., Gibson, D. M., Ketchum, R. E. B., Hirasuna, T. J., Shuler, M. L., Holton, R. A., Blediger, R. J., et al. (1995) · Cited by 340
Self-citationNatural products and combinatorial chemistry: back to the future
Ortholand, J.-Y., & Ganesan, A. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.011 · Cited by 336
Pettit, G. R., Singh, S. B., Niven, M. L., Hamel, E., & Schmidt, J. M. (1987) · Journal of Natural Products · doi:10.1021/np50049a016 · Cited by 328
Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry, S. L., Tien, G., Hernandez, A. H., Plubrukarn, A., & Davidson, B. S. (1999) · PubMed · Cited by 324
Dolastatin 10, a powerful cytostatic peptide derived from a marine animal
Bai, R., Petit, G. R., & Hamel, E. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90613-p · Cited by 321
Insights into the mechanism of microtubule stabilization by Taxol
Xiao, H., Verdier-Pinard, P., Fernandez-Fuentes, N., Burd, B., Angeletti, R., Fiser, A., Horwitz, S. B., & Orr, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603704103 · Cited by 319
Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules
Lindel, T., Jensen, P. R., Fenical, W., Long, B. H., Casazza, A. M., Carboni, J., & Fairchild, C. R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9717828 · Cited by 293
Bai, R. L., Pettit, G. R., & Hamel, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44880-0 · Cited by 286
How Do Microtubule-Targeted Drugs Work? An Overview
Jordan, M., & Kamath, K. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907783220417 · Cited by 270
Vascular disrupting agents in clinical development
Hinnen, P., & Eskens, F. A. L. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603694 · Cited by 263
Nicholson, B., Lloyd, G. K., Miller, B. R., Palladino, M. A., Kiso, Y., Hayashi, Y., & Neuteboom, S. T. C. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000182745.01612.8a · Cited by 260
Pryor, D. E., O'Brate, A., Bilcer, G., Díaz, J. F., Wang, Y., Wang, Y., Kabaki, M., Jung, M. K., Andreu, J. M., Ghosh, A. K., et al. (2002) · Biochemistry · doi:10.1021/bi020211b · Cited by 256
Altmann, K.-H., & Gertsch, J. (2007) · Nat. Prod. Rep. · doi:10.1039/b515619j · Cited by 248
3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin.
Rao, S., Krauss, N. E., Heerding, J. M., Swindell, C. S., Ringel, I., Orr, G. A., & Horwitz, S. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41836-9 · Cited by 245
Characterization of the Taxol Binding Site on the Microtubule
Rao, S., Orr, G. A., Chaudhary, A. G., Kingston, D. G. I., & Horwitz, S. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20235 · Cited by 235
Self-citationLong, B. H., Carboni, J. M., Wasserman, A. J., CORNELL, L., Casazza, A. M., Jensen, P. R., Lindel, T., Fenical, W., & Fairchild, C. R. (1998) · PubMed · Cited by 218
Pettit, G. R., Herald, C. L., Boyd, M. R., Leet, J. E., Dufresne, C., Doubek, D. L., Schmidt, J. M., Cerny, R. L., Hooper, J. N. A., & Rutzler, K. C. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a027 · Cited by 191
Localization of the Vinblastine-binding Site on β-Tubulin
Rai, S. S., & Wolff, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14707 · Cited by 165
Macrocyclic ketone analogues of halichondrin B
Zheng, W., Seletsky, B. M., Palme, M. H., Lydon, P. J., Singer, L. A., Chase, C. E., Lemelin, C. A., Shen, Y., Davis, H., Tremblay, L., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.069 · Cited by 163
Anderson, H. J., Coleman, J. E., Andersen, R. J., & Roberge, M. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050564 · Cited by 160
Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid
Kruczynski, A., Barret, J.-M. M., Etiévant, C., Colpaert, F. C., Fahy, J., & Hill, B. T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00505-4 · Cited by 149
Clinical status of anti-cancer agents derived from marine sources
Singh, R., Sharma, M., Joshi, P., & Rawat, D. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785133074 · Cited by 143
Borzilleri, R. M., Zheng, X., Schmidt, R. J., Johnson, J. A., Kim, S., DiMarco, J. D., Fairchild, C. R., Gougoutas, J. Z., Lee, F. Y., Long, B. H., et al. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001899n · Cited by 143
Targeting the Microtubules in Breast Cancer Beyond Taxanes: The Epothilones
Cortés, J., & Baselga, J. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-271 · Cited by 137
The Total Synthesis of Eleutherobin
Chen, X., Bhattacharya, S. K., Zhou, B., Gutteridge, C. E., Pettus, T. R. R., & Danishefsky, S. J. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990215c · Cited by 133
The Chemistry and Biology of Epothilones—The Wheel Keeps Turning
Altmann, K., Pfeiffer, B., Arseniyadis, S., Pratt, B. A., & Nicolaou, K. C. (2007) · ChemMedChem · doi:10.1002/cmdc.200600206 · Cited by 130
Klar, U., Buchmann, B., Schwede, W., Skuballa, W., Hoffmann, J., & Lichtner, R. B. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602785 · Cited by 124
Hori, K., & Saito, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601261 · Cited by 123
Vascular-targeting activity of ZD6126, a novel tubulin-binding agent.
Micheletti, G., Poli, M., Borsotti, P., Martinelli, M., Imberti, B., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 117
Cisternino, S., Bourasset, F., Archimbaud, Y., Sémiond, D., Sanderink, G., & Scherrmann, J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705150 · Cited by 111
Ganesh, T., Guza, R., Bane, S., Ravindra, R., Shanker, N., Lakdawala, A. S., Snyder, J. P., & Kingston, D. G. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403459101 · Cited by 110
Self-citationEfficacy of Selected Natural Products as Therapeutic Agents against Cancer
Banerjee, S., Wang, Z., Mohammad, M., Sarkar, F. H., & Mohammad, R. M. (2008) · Journal of Natural Products · doi:10.1021/np0705716 · Cited by 107
Paclitaxel for non-small cell lung cancer
Ramalingam, S., & Belani, C. P. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1771 · Cited by 107
Henderson, I. C., & Bhatia, V. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.7.919 · Cited by 102
Rivkin, A., Yoshimura, F., Gabarda, A. E., Chou, T., Dong, H., Tong, W. P., & Danishefsky, S. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029695p · Cited by 94
Current development status of small-molecule vascular disrupting agents.
Chaplin, D. J., Horsman, M. R., & Siemann, D. W. (2006) · PubMed · Cited by 94
Negishi, T., Koizumi, F., Uchino, H., Kuroda, J.-I., Kawaguchi, T., Naito, S., & Matsumura, Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603311 · Cited by 92
Marine Animal Biosynthetic Constituents For Cancer Chemotherapy
Pettit, G. R., Kamano, Y., Fujii, Y., Herald, C. L., Inoue, M., Brown, P., Gust, D., Kitahara, K., Schmidt, J. M., Doubek, D. L., et al. (1981) · Journal of Natural Products · doi:10.1021/np50016a016 · Cited by 88
Current Status of Research on the Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don)
Svoboda, G. H., Johnson, I. S., Gorman, M., et al. (1962) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600510802 · Cited by 86
(+)-Discodermolide: total synthesis, construction of novel analogues, and biological evaluation
Smith, A. B., & Freeze, B. S. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.10.039 · Cited by 82
Tumour targeting by microtubule-depolymerising vascular disrupting agents
Kanthou, C., & Tozer, G. M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1443 · Cited by 81
Epothilones in the treatment of cancer
Larkin, J., & Kaye, S. B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.6.691 · Cited by 76
Figgitt, D. P., & Wiseman, L. R. (2000) · Drugs · doi:10.2165/00003495-200059030-00015 · Cited by 72
Jones, R. J., Hawkins, R. E., Eatock, M. M., Ferry, D. R., Eskens, F. A. L. M., Wilke, H., & Evans, T. R. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0486-8 · Cited by 71
Structurally simplified macrolactone analogues of halichondrin B
Seletsky, B. M., Wang, Y., Hawkins, L. D., Palme, M. H., Habgood, G. J., DiPietro, L., Towle, M. J., Salvato, K. A., Wels, B. F., Aalfs, K. K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.068 · Cited by 71
Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin
Ludueña, R. F., Roach, M. C., Prasad, V., & Pettit, G. R. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90079-c · Cited by 70
Marine Peptides and Related Compounds in Clinical Trial+
Rawat, D. S., Joshi, M. C., Joshi, P., & Atheaya, H. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006774755519 · Cited by 68
Mita, A. C., Hammond, L. A., Bonate, P. L., Weiss, G. R., McCreery, H., Syed, S. K., Garrison, M. A., Chu, Q. S.-C., Bono, J. S. D., Jones, C. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0179 · Cited by 68
Initial studies on the cytotoxic action of maytansine, a novel ansa macrolide
Wolpert-DeFilippes, M. K., Adamson, R. H., Cysyk, R. L., & Johns, D. G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90257-9 · Cited by 62
Conlin, A. K., Fornier, M. N., Hudis, C. A., Kar, S., & Kirkpatrick, P. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2469 · Cited by 60
Rational Design of the Microtubule-Targeting Anti–Breast Cancer Drug EM015
Aneja, R., Lopus, M., Zhou, J., Vangapandu, S. N., Ghaleb, A. M., Yao, J. L., Nettles, J. H., Zhou, B., Gupta, M. V., Panda, D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2962 · Cited by 55
Ray, A., Okouneva, T., Manna, T. K., Miller, H. P., Schmid, S. M., Arthaud, L. E., Ludueña, R. F., Jordan, M. A., & Wilson, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3065 · Cited by 55
Payne, M., Ellis, P., Dunlop, D. J., Ranson, M., Danson, S. J., Schacter, L., & Talbot, D. C. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31631-2 · Cited by 52
Cunningham, C. C., Appleman, L. J., Visovatti, M. A., Ryan, D. P., Regan, E. M., Vukelja, S. J., Bonate, P. L., Ruvuna, F., Fram, R. J., Jekunen, A. P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0058 · Cited by 51
Docetaxel: A tubulin-stablizing agent approved for the management of several solid
Ramaswamy, B., & Puhalla, S. (2006) · Drugs of today · doi:10.1358/dot.2006.42.4.968648 · Cited by 48
Docetaxel in non-small cell lung cancer: a review
Davies, A. M., Lara, P. N., Mack, P. C., et al. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.4.553 · Cited by 48
Bonomi, P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.415 · Cited by 46
Gralla, R. J., Gatzemeier, U., Gebbia, V., Huber, R. M., Brien, M. O., & Puozzo, C. (2007) · Drugs · doi:10.2165/00003495-200767100-00003 · Cited by 40
Ferlini, C., Gallo, D., & Scambia, G. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.335 · Cited by 40
Ramanathan, R. K., Picus, J., Raftopoulos, H., Bernard, S. A., Lockhart, A. C., Frenette, G., Macdonald, J. S., Melin, S. A., Berg, D., Brescia, F., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0489-5 · Cited by 37
Epothilones and new analogues of the microtubule modulators in taxane-resistant disease
Harrison, M., & Swanton, C. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.523 · Cited by 32
Joel, S. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90015-2 · Cited by 30
Newman, S. (2007) · PubMed · Cited by 29
Schuch, G. (2005) · PubMed · Cited by 19
du Bois, A., Jung, B., Loehr, A., Schaller-Kranz, T., Cohen, M., & Frickhofen, N. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602886 · Cited by 9
Neue Mikrotubuli‐Stabilisatoren: Jenseits von Paclitaxel und Docetaxel
Baumann, K. (2005) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200400110 · Cited by 4
Cited by
Metabolism and roles of stilbenes in plants
Chong, J., Poutaraud, A., & Hugueney, P. (2009) · Plant Science · doi:10.1016/j.plantsci.2009.05.012 · Cited by 664
Secondary metabolites of fungi from marine habitats
Rateb, M. E., & Ebel, R. (2011) · Natural Product Reports · doi:10.1039/c0np00061b · Cited by 645
Drugs that target dynamic microtubules: A new molecular perspective
Stanton, R. A., Gernert, K. M., Nettles, J. H., & Aneja, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20242 · Cited by 526
Dhyani, P., Quispe, C., Sharma, E., Bahukhandi, A., Sati, P., Attri, D. C., Szopa, A., Sharifi-Rad, J., Docea, A. O., Mardare, I., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02624-9 · Cited by 483
A Papaver somniferum 10-Gene Cluster for Synthesis of the Anticancer Alkaloid Noscapine
Winzer, T., Gazda, V., He, Z., Kaminski, F., Kern, M., Larson, T. R., Li, Y., Meade, F., Teodor, R., Vaistij, F. E., et al. (2012) · Science · doi:10.1126/science.1220757 · Cited by 337
Metadata
- Authors
- Kingston, D. G. I.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-01-06
- Volume
- 72
- Issue
- 3
- Pages
- 507-515
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2035210263
- Cited by
- 328
- References
- 94
- FWCI
- 13.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.